Empower Clinics Announces April 2020 Patient Growth of 871% and Orders Additional Supplies for Covid-19 Testing

Shares :

0
(0)

VANCOUVER, BC / ACCESSWIRE / May 5, 2020 / EMPOWER CLINICS INC.(CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“), a vertically integrated life sciences company, is pleased to announce that patient visits in corporate clinics increased by 871% in April 2020 versus the same period in 2019, with total patient visits of 2,212 in April 2020 compared to 254 in April 2019.

The Company is booking new physician appointments for immune boosting services that are leading to naturopathic product sales and the ordering of specialized tests. In addition, the Company has increased orders of Personal Protective Equipment (PPE) and equipment such as stainless-steel tables, portable air conditioning units, tents and medical supplies to support staff and patients as part of a medical testing protocol in the United States.

The Company has also been identified by Amazon Business as needing access to critical supplies and as such, the Company has been awarded access to the Amazon COVID-19 SUPPLIES portal, which provides access to essential products for organizations participating in the fight against Coronavirus.

“The performance results from April are truly outstanding and given the operational changes the team have made as a result of Coronavirus, I am immensely proud of their efforts” said Steven McAuley, Chairman & CEO of Empower. “We are starting to see strong diversification in the revenue model for our clinics that will help us grow not only patient count, but revenue per patient, total revenue and perhaps more importantly, create revenue diversity to reduce concentration risk for the business model.”

ABOUT EMPOWER

Empower is a vertically integrated health & wellness brand with a network of corporate and franchised health & wellness clinics in the U.S. The Company is building its first hemp-derived CBD extraction facility and produces its proprietary line of cannabidiol (CBD) based products. The Company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company now offers COVID-19 testing options in the United States and physician-based consultations, to address COVID-19 concerns.


This image has an empty alt attribute; its file name is revivelogo2.2.png

REVIVE THERAPEUTICS | RVV HUGE NEWS

Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial


LAST ALERT MADE MORE THAN 360% TO DATE !



This article is written and published by The Cannabis Stock


Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies

The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.


Click on a star to rate this article !

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.


Shares :